340 related articles for article (PubMed ID: 15603533)
1. International note. Antibiotics in the management of shigellosis.
Can Commun Dis Rep; 2004 Dec; 30(23):202-3. PubMed ID: 15603533
[No Abstract] [Full Text] [Related]
2. Antibiotics in the management of shigellosis.
Wkly Epidemiol Rec; 2004 Sep; 79(39):355-6. PubMed ID: 15571173
[No Abstract] [Full Text] [Related]
3. Increasing incidence of resistance to nalidixic acid in shigellas from humans in England and Wales: implications for therapy.
Cheasty T; Day M; Threlfall EJ
Clin Microbiol Infect; 2004 Nov; 10(11):1033-5. PubMed ID: 15522014
[TBL] [Abstract][Full Text] [Related]
4. Drug resistant shigellosis in south India.
Paniker CK; Vimala KN; Bhat P; Stephen S
Indian J Med Res; 1978 Sep; 68():413-7. PubMed ID: 744630
[No Abstract] [Full Text] [Related]
5. Shigellosis in Puducherry.
Dhodapkar R; Acharya NS; Harish BN; Parija SC
Indian J Med Res; 2008 Jun; 127(6):621-2. PubMed ID: 18765885
[No Abstract] [Full Text] [Related]
6. Drug resistance of Shigella species: changes over 20 years in Turkey.
Ergönül O; Imre A; Celikbaş A; Dokuzoğuz B
Int J Antimicrob Agents; 2004 May; 23(5):527-8. PubMed ID: 15120738
[No Abstract] [Full Text] [Related]
7. Shigella Antimicrobial Drug Resistance Mechanisms, 2004-2014.
Nüesch-Inderbinen M; Heini N; Zurfluh K; Althaus D; Hächler H; Stephan R
Emerg Infect Dis; 2016 Jun; 22(6):1083-5. PubMed ID: 27191035
[TBL] [Abstract][Full Text] [Related]
8. Emergence of nalidixic acid resistance in Shigella sonnei isolated from patients having acute diarrheal disease: report from eastern province of Saudi Arabia.
Panhotra BR; Saxena AK; Al-Mulhim K
Jpn J Infect Dis; 2004 Jun; 57(3):116-8. PubMed ID: 15218222
[TBL] [Abstract][Full Text] [Related]
9. Death from multi-resistant shigellosis in Fiji Islands.
Watson C
Pac Health Dialog; 2001 Mar; 8(1):99-102. PubMed ID: 12017845
[TBL] [Abstract][Full Text] [Related]
10. Changing patterns of serotypes and antimicrobial susceptibilities of Shigella species isolated from children in Calcutta, India.
Niyogi SK; Mitra U; Dutta P
Jpn J Infect Dis; 2001 Jun; 54(3):121-2. PubMed ID: 11544405
[No Abstract] [Full Text] [Related]
11. [On the resistance of dysentery bacteria to antibiotics].
Serebrainskiĭ VS
Voen Med Zh; 1969 Feb; 2():45-7. PubMed ID: 5772336
[No Abstract] [Full Text] [Related]
12. Treatment of drug-resistant Shigella infections.
Klontz KC; Singh N
Expert Rev Anti Infect Ther; 2015 Jan; 13(1):69-80. PubMed ID: 25399653
[TBL] [Abstract][Full Text] [Related]
13. Epidemic dysentery caused by Shigella dysenteriae type 1: a sentinel site surveillance of antimicrobial resistance patterns in Burundi.
Engels D; Madaras T; Nyandwi S; Murray J
Bull World Health Organ; 1995; 73(6):787-91. PubMed ID: 8907772
[TBL] [Abstract][Full Text] [Related]
14. Increasing resistance to nalidixic acid in Shigella subgroups in a comparative study between 2001-2003 and 2004-2006.
Mamishi S; Mashoori N; Mahboobi N; Pour Akbari B
Singapore Med J; 2009 Aug; 50(8):791-3. PubMed ID: 19710978
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of determining the sensitivity of dysentery microbes to antibiotics].
Bochorishvili VG; Gegiia TN; Bibineĭshvili MV; Giorgobiani ES; Ukleba KD
Sov Med; 1972 May; 35(5):63-6. PubMed ID: 5042690
[No Abstract] [Full Text] [Related]
16. [Considerations on dysentery caused by Shigella with multiple resistance to antibiotics].
Brauner E; Cuciureanu G; Hurmuzache T; Turcu T; Grigoriu A; Cercel I
Microbiol Parazitol Epidemiol (Bucur); 1969; 14(3):221-6. PubMed ID: 5344218
[No Abstract] [Full Text] [Related]
17. Nalidixic acid is still the drug of choice for shigellosis in Pakistan.
Mahmood A
J Pak Med Assoc; 2001 Feb; 51(2):101. PubMed ID: 11321869
[No Abstract] [Full Text] [Related]
18. Treatment of shigellosis: V. Comparison of azithromycin and ciprofloxacin. A double-blind, randomized, controlled trial.
Khan WA; Seas C; Dhar U; Salam MA; Bennish ML
Ann Intern Med; 1997 May; 126(9):697-703. PubMed ID: 9139555
[TBL] [Abstract][Full Text] [Related]
19. Death from multi-resistant shigelloses: a case study from Fiji.
Watson C
Pac Health Dialog; 2006 Sep; 13(2):111-4. PubMed ID: 18181399
[TBL] [Abstract][Full Text] [Related]
20. Nalidixic acid in resistant shigella infection.
Agrawal ML; Mukherjee SP; Prasad SS
J Assoc Physicians India; 1987 May; 35(5):390. PubMed ID: 3693298
[No Abstract] [Full Text] [Related]
[Next] [New Search]
